Seeking Alpha

Cornerstone Therapeutics (CRTX -11.5%) plummets after saying it has received a letter from Exela...

Cornerstone Therapeutics (CRTX -11.5%) plummets after saying it has received a letter from Exela Pharma regarding the filing of an NDA for a product similar to CRTX's CARDENE I.V. Premixed Injection. The company says it will "pursue all available legal and regulatory avenues in defense" of CARDENE. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs